Value-Based Care

A new joint venture in Florida isn't just an expansion; it's a calculated move to dominate the post-acute market by combining national scale with local trust.

Beyond profits, a new ranking reveals how employee satisfaction and societal impact are becoming the true markers of commercial success in a turbulent industry.

Beyond the annual physical, a new model of virtual, year-round wellness is emerging. Veo Health’s Atlanta launch shows why firms see it as a key strategy.

A new service moves beyond data, using AI and human guides to steer patients to affordable care. Is this the strategy that finally bends the healthcare cost curve?

Covera Health's new Chief Clinical Officer isn't just another exec. Dr. Evan Raff's unique background signals a shift from AI hype to real-world results.

GMR Solutions adds Optum and Tufts veterans to its board, a strategic move to transform EMS from a transport service into an integrated healthcare pillar.

With a new $110M raise and rare profitability, Pearl Health's platform isn't just predicting illness—it's proving that technology can fix healthcare's broken model.

A new partnership aims to turn saliva into a data-rich asset, signaling a major shift in the health tech market from reactive treatment to proactive care.

As GLP-1 drugs surge in popularity, one company is betting on a new model for seniors that pairs prescriptions with strength training to fight muscle loss.

A new hospital network in Bangalore is giving clinicians equity, betting that ownership can restore trust and improve care. It's a bold test for a new model.

Mantra Health's new policy chief isn't just a hire; it's a strategic move to re-engineer student mental health funding, linking well-being to economic success.

A new automated system promises health plans a 10:1 ROI by tiering medical specialists. But as QualiTier™ scrutinizes doctors, it faces its own test of trust.

In a crowded market, independent validation is the new currency. Vida Health’s DiMe Seal signals a major shift from marketing hype to proven results.

Beyond the hype, an AI assistant is quietly revolutionizing patient care. We explore how Counterpart Health's tool is bridging critical gaps and what it means for doctors and patients.

Pediatrica Health's $28M Series B aims to fix a broken system. With investors betting on 'equitable access,' is this the future of child healthcare?

Shilpa Medicare and Orion Corp. partner on a nivolumab biosimilar, challenging Big Pharma and promising affordable access to a vital cancer immunotherapy.

A new video series from Anthem and USA TODAY aims to educate consumers. But is it a public service or a sophisticated marketing strategy to cut costs?

A new $200K award isn't just a grant; it's a strategic bet on systems engineering to fix a diagnostic pathway where 70% of lung cancer cases are found too late.

New data reveals a deep divide in who can access revolutionary weight-loss drugs, exposing a market that is both booming and profoundly under-penetrated.